- Home
- LXEO vs INMD Comparison
LXEO vs INMD Comparison
Compare LXEO & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LXEO | INMD |
|---|---|---|
| Founded | 2017 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 731.3M | 861.7M |
| IPO Year | 2023 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LXEO | INMD |
|---|---|---|
| Price | $6.84 | $13.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 6 |
| Target Price | ★ $18.60 | $16.75 |
| AVG Volume (30 Days) | 644.7K | ★ 951.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 75.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $654,000.00 | N/A |
| Revenue This Year | N/A | $1.70 |
| Revenue Next Year | N/A | $3.99 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.45 | $13.16 |
| 52 Week High | $10.99 | $19.78 |
Technical Indicators
Market Signals| Indicator | LXEO | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 34.62 |
| Support Level | $6.15 | N/A |
| Resistance Level | $7.72 | $14.80 |
| Average True Range (ATR) | 0.43 | 0.32 |
| MACD | 0.11 | -0.12 |
| Stochastic Oscillator | 57.00 | 1.93 |
Price Performance
Historical ComparisonAbout LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.